Featured Research

from universities, journals, and other organizations

Smoking affects molecular mechanisms, children's immune systems

Date:
October 7, 2013
Source:
Helmholtz Centre For Environmental Research - UFZ
Summary:
Researchers have gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children how exposure to tobacco smoke affects the development of human immune system on molecular level. The focus was on microRNA – a short, single-stranded RNA molecule that is now recognized as playing an important role in gene regulation. 

In addition to nicotine, there are some 4800 other chemicals found in cigarette smoke, many of which are harmful to health.
Credit: Kristin Junge/ UFZ

The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level. The focus thereby was on microRNA -- a short, single-stranded RNA molecule that is now recognised as playing an important role in gene regulation.

For some time now, the impact of environmental stressors during pregnancy on allergy risk among new-born children is a main research topic at Leipzig Helmholtz Center for Environmental Research (UFZ). As part of the long-term study LINA, environmental immunologists from Leipzig have been focussing on tobacco smoke as an environmental stressor. The main objective for Dr Gunda Herberth was to reveal the influence of tobacco smoke on the development of children's immune systems -- at molecular level. From the results that were recently published in the Journal of Allergy and Clinical Immunology, one thing is certain: "For the first time we were able to describe the effect of prenatal environmental stressors on the regulation of microRNA."

Former studies have already proven that smoking during pregnancy can harm the unborn child: Newborns from smoking mothers have shown low birth weights and impaired lung functions; later on in life respiratory diseases, diabetes type II, asthma or cardiovascular diseases were also more common. However, the exact molecular mechanisms and processes that are behind such developments still struggle researchers.

For this reason, Dr. Gunda Herberth and Dr. Irina Lehmann from the UFZ decided to address the relatively recent research area of microRNA. From the early 1990΄s these cell components started to become more and more of a focus in molecular and cell biology. In the meantime, for humans more than 1,200 different short, single-stranded RNA molecules have been named, some of them playing an important role in immune response. Among others, they have a considerable influence on the differentiation of regulatory T cells (Treg cells), which in turn prevent an overactive immune system and thus autoimmune diseases. If there are insufficient Treg cells or if their function is impaired, the self-regulatory function of the immune system will be reduced, possibly resulting in allergies.

To investigate the relationship between smoking mothers during pregnancy on the one hand and their children΄s risk of developing allergies on the other, the scientists from Leipzig examined microRNA-223, microRNA-155 and regulatory T cells -- not only in the blood samples of pregnant women (36 weeks pregnant) but also at birth in the cord blood of their babies. At the same time, questionnaires were filled out and urine samples of the pregnant women were tested to substantiate the effect from exposure to tobacco smoke and/or from volatile organic compounds resulting from smoking. From the pool of mothers participating in the LINA-study, 315 mothers (6.6 percent of whom were smokers) and 441 children were consulted in these investigations.

The focus was on miR-223 and miR-155, because their role in regulating T cells had already been proven. "What we are now interested in finding out," explains Dr. Gunda Herberth , "is whether or not these microRNAs link exposure to smoke, regulatory T cells and the risk of developing allergies."

By measuring the concentration of these microRNAs as well as the number of regulatory T cells in maternal and cord blood it could be shown that a high exposure to inhaled volatile organic compounds (VOCs) associated with tobacco smoke coincides with high values for miR-223. At the same time it was also found that increased values for maternal and umbilical cord blood miR-223 correlate with low regulatory T-cell numbers. Finally, it could be shown that low regulatory T-cell numbers in umbilical cord blood was an indication that children exposed to tobacco smoke were more likely to develop an allergy before the age of three compared to those children with normal values for miR-223 and Treg cells. Furthermore, the probability of developing eczema was almost twice as high for these children.

"After already being able to demonstrate the influence of prenatal smoking on regulatory T-cell numbers in cord blood from our LINA study, the current epidemiological investigation delves even deeper into molecular processes," Dr. Gunda Herberth and Dr. Irina Lehmann resume. "Now," the immunologists from Leipzig explicate, "we will know more about the molecular processes that trigger off stressors from smoke during pregnancy." Thus, for the first time the association between prenatal environmental stressors and the regulation of microRNA is described. In this respect, the current Helmholtz study opens the door to further research on the role of microRNA in terms of how the human immune system reacts to environmental stressors.


Story Source:

The above story is based on materials provided by Helmholtz Centre For Environmental Research - UFZ. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gunda Herberth, Mario Bauer, Michaela Gasch, Denise Hinz, Stefan Rφder, Sven Olek, Tibor Kohajda, Ulrike Rolle-Kampczyk, Martin von Bergen, Ulrich Sack, Michael Borte, Irina Lehmann. Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers. Journal of Allergy and Clinical Immunology, 2013; DOI: 10.1016/j.jaci.2013.06.036

Cite This Page:

Helmholtz Centre For Environmental Research - UFZ. "Smoking affects molecular mechanisms, children's immune systems." ScienceDaily. ScienceDaily, 7 October 2013. <www.sciencedaily.com/releases/2013/10/131007094324.htm>.
Helmholtz Centre For Environmental Research - UFZ. (2013, October 7). Smoking affects molecular mechanisms, children's immune systems. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/10/131007094324.htm
Helmholtz Centre For Environmental Research - UFZ. "Smoking affects molecular mechanisms, children's immune systems." ScienceDaily. www.sciencedaily.com/releases/2013/10/131007094324.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins